NIH
$225,000
STTR Award
National Institutes of Health · Awarded May 2023
Translational validation and preclinical proof of concept for low-voltage reversible electroporation.
NIH
$2,000,000
SBIR Direct to Phase II
National Institutes of Health · Awarded September 2025
Advanced human platform commercialization, electrode miniaturization, and pancreatic trial readiness.